Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Actinium-225 conjugated to daratumumab
i
Other names:
Actinium-225 conjugated to daratumumab
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
Actinium
Drug class:
CD38-targeted antibody-drug conjugate, Ionizing radiation emitter
Related drugs:
‹
STI-6129 (1)
samarium-153 DOTMP (0)
Radspherin (0)
rhenium Re186 obisbemeda (0)
STI-6129 (1)
samarium-153 DOTMP (0)
Radspherin (0)
rhenium Re186 obisbemeda (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
CD38 positive
Multiple Myeloma
CD38 positive
Multiple Myeloma
Actinium-225 conjugated to daratumumab
Sensitive: D – Preclinical
Actinium-225 conjugated to daratumumab
Sensitive
:
D
Actinium-225 conjugated to daratumumab
Sensitive: D – Preclinical
Actinium-225 conjugated to daratumumab
Sensitive
:
D
CD38 positive
Burkitt Lymphoma
CD38 positive
Burkitt Lymphoma
Actinium-225 conjugated to daratumumab
Sensitive: D – Preclinical
Actinium-225 conjugated to daratumumab
Sensitive
:
D
Actinium-225 conjugated to daratumumab
Sensitive: D – Preclinical
Actinium-225 conjugated to daratumumab
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.